Drug Alerts and Special Reports

Key reimbursement alerts for office-administered drugs — C-Code, J-Code, NDC, and NCCN alerts plus pricing updates, sent on behalf of pharma manufacturers.

Subscribe To Newsletter

Pricing 02/14/2023

Announcing a Price Change for Paragard (intrauterine copper contraceptive) - 12/16/22

Announcing a Price Change for Paragard® (intrauterine copper contraceptive) Paragard Customer, Effective December 31, 2022, the pricing of Paragard will change as outlined below. Please take a moment to update any of your reimbursement, billing, and ordering systems to reflect this change. PARAGARD PRICING AND CODING INFORMATION: HCPCS Code Labeler 11 Digit NDC Price Effective Date Product Description WAC Estimated AWP J7300…

Pricing 02/14/2023

Important Price Change Announcement for Photrexa - 12/13/22

Important Price Change Announcement for Photrexa® This email is being sent by BuyandBill.com on behalf of Glaukos ® , Inc. Announcing New Pricing for Photrexa ® Cross-Linking Kit As of January 1, 2023 Item Code/Price Description HCPCS Code J2787 Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml NDC Number 25357-0025-03 A cross linking kit contains one Photrexa Viscous 3 ml single-patient use syringe and one Photrexa solution 3 ml…

NDC 02/14/2023

New NDC and dose for TURALIO (pexidartinib) - 11/7/22

New NDC and dose for TURALIO® (pexidartinib) (see Prescribing Information and Boxed WARNING) DSI041-TUR-A-02 96 TK ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ TURALIO ® New Dosing Regimen Approved in the U.S. Approved in the U.S. The dosing change is being made due to the known effects food has on the absorption of TURALIO and the potential for drug overexposure that could happen if a patient takes the TURALIO 200…

NDC 02/14/2023

NEW NDC FOR ZILRETTA (triamcinolone acetonide) - 10/17/22

ACTION REQUIRED: NEW NDC FOR ZILRETTA® (triamcinolone acetonide Pacira BioSciences, Inc. acquired Flexion Therapeutics and ZILRETTA. A new NDC has been issued to reflect the updated labeler code for ZILRETTA . Effective October 10, 2022, a new ZILRETTA NDC will be available: 65250-0003-01 HCPCS Code HCPCS Code Descriptor NDC Number Labeler NDC Description J3304 Injection triamcinolone acetonide, preservative free, extended release…

FDA Approved 02/14/2023

Now Approved: RELYVRIO: new ALS treatment option for your members - 10/13/22

Now approved: new ALS treatment option for your members 96 ================================================================================================================================= we need 1k of characters in the head to prevent iOS devices from displaying the "download rest of message"... message... ************************************************************************************************************…

02/14/2023

Effective October 1, 2022: J1932: A unique HCPCS code for Cipla's Lanreotide Depot - 10/3/2022

Effective October 1, 2022: J1932: A unique HCPCS code for Cipla's Lanreotide Depot Effective October 1, 2022: J1932, injection, lanreotide, (Cipla), 1 mg, is available for all sites of care. J1932 is a unique HCPCS code for Cipla's version of Lanreotide Depot and should not be used for billing other lanreotide formulations. HCPCS Code HCPCS Code Descriptor NDC Number How Supplied ASP Per HCPCS Unit (1 mg) HCPCS Units Per Package…

02/14/2023

Effective October 1, 2022: J9274, Injection, tebentafusp-tebn, 1 microgram for KIMMTRAK - 9/22/22

Effective October 1, 2022: J9274, Injection, tebentafusp-tebn, 1 microgram for KIMMTRAK® Effective For Dates of Service Beginning October 1, 2022 KIMMTRAK Permanent J-Code Now Available J9274 Injection, tebentafusp-tebn, 1 microgram KIMMTRAK Coding Details: HCPCS Code HCPCS Code Description NDC NDC Description HCPCS Units Per Package WAC* Per HCPCS Unit J9274 Injection, tebentafusp-tebn, 1 mcg 80446-0401-01 Single Dose Vial Containing…

J-Code 02/14/2023

Announcing A Permanent J-Code for Opdualag - 9/29/22

Announcing A Permanent J-Code for a BMS Oncology Product J9298 Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg J9298 Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg EFFECTIVE FOR DATES OF SERVICE ON OR AFTER OCTOBER 1, 2022: The following HCPCS code may be used to identify OPDUALAG™ (nivolumab and relatlimab-rmbw) J9298 Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg Opdualag is a fixed-dose combination: a co-formulation of…

02/14/2023

ENHERTU: New Indication - 9/28/22

New indication, now approved: ENHERTU® (fam-trastuzumab deruxtecan-nxki) New indication, now approved: ENHERTU® (fam-trastuzumab deruxtecan-nxki) 96 Find out about this new treatment option. Review the PI and Boxed WARNINGS here. ENHERTU ® (fam-trastuzumab deruxtecan-nxki) is NOW APPROVED for the treatment of unresectable or metastatic activating HER2 -mutant 2L non-small cell lung cancer (NSCLC) INDICATION ENHERTU is a HER2-directed…

J-Code 02/14/2023

Coming Soon: Permanent J Code ( J2777) for Vabysmo - 8/30/22

Coming Soon: A Permanent J-code (J2777) for VABYSMO® Coming Soon: A Permanent J-code (J2777) for VABYSMO ® effective for services beginning October 1, 2022 A permanent J-code will go into effect for dates of service beginning October 1, 2022. J2777: Injection, faricimab-svoa, 0.1 mg Please ensure your systems are updated to accept J2777 for VABYSMO for services starting October 1, 2022 VABYSMO NDC Code 50242-0096-01: VABYSMO (6…

1 … 151617

No alerts match your filters.